1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 11 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Which substitution pharmacotherapy is most effective in treating opioid dependence?Gowing, L.; Ali, R.; White, J.
2009Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulationDegenhardt, L.; Larance, B.; Bell, J.; Winstock, A.; Lintzeris, N.; Ali, R.; Scheuer, N.; Mattick, R.
2021Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomesJones, N.R.; Nielsen, S.; Farrell, M.; Ali, R.; Gill, A.; Larney, S.; Degenhardt, L.
2005Short-term outcomes of five heroin detoxification methods in the Australian NEPOD projectDigiusto, E.; Lintzeris, N.; Breen, C.; Kimber, J.; Mattick, R.; Bell, J.; Ali, R.; Saunders, J.
2003Buprenorphine versus methadone maintenance: a cost-effectiveness analysisDoran, C.; Shanahan, M.; Mattick, R.; Ali, R.; White, J.; Bell, J.
2005The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS)Ross, J.; Teesson, M.; Darke, S.; Lynskey, M.; Ali, R.; Ritter, A.; Cooke, R.
2008Electrocardiogram characteristics of methadone and buprenorphine maintained subjectsAthanasos, P.; Farquharson, A.; Compton, P.; Psaltis, P.; Hay, J.
2011Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosingLarance, B.; Degenhardt, L.; Lintzeris, N.; Bell, J.; Winstock, A.; Dietze, P.; Mattick, R.; Ali, R.; Horyniak, D.
2012Maintenance drugs to treat opioid dependenceFarrell, M.; Wodak, A.; Gowing, L.
2013Mitigating the risk of HIV infection with opioid substitution treatmentGowing, L.; Hickman, M.; Degenhardt, L.

Discover